Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Reig Jofré Group in connection with the business acquisition of Bioglan AB
Mandate

Vinge advises Reig Jofré Group in connection with the business acquisition of Bioglan AB

September 07, 2009

Vinge has advised Reig Jofré Group in connection with the acquisition of the business of Bioglan AB from Midelfart Sonesson. Reig Joflé Group is one of the leading companies in Spain within the pharmaceuticals industry. Bioglan AB conducts operations in relation to contract development and manufacture of dermatological pharmaceuticals under the supervision of the Swedish Medical Products Agency.

Reig Jofré Group was advised by partner Peter Abrahamsson and associates Kristian Ford, Andreas Schöldström, Marcus Bergdahl, Anna Bjering and Anna Bergstrand.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026